Deng Liang, Yang Shi-Bin, Xu Feng-Feng, Zhang Ji-Hong
Department of Hepatobiliary Surgery, The Eastern Hospital of the First Affiliated Hospital, Sun Yat-sen University, Eastern Huangpu Road No. 183, Guangzhou, 510700, China.
Department of Gastrointestinal and Pancreatic Surgery, The Eastern Hospital of the First Affiliated Hospital, Sun Yat-sen University, Eastern Huangpu Road No. 183, Guangzhou, 510700, China.
J Exp Clin Cancer Res. 2015 Feb 19;34(1):18. doi: 10.1186/s13046-015-0136-7.
Long noncoding RNAs (lncRNAs) have been identified as having functional roles in cancer biology and are deregulated in many cancers. The present study aimed to determine the expression, roles and functional mechanisms of a long noncoding RNA CCAT1 in the progression of hepatocellular carcinoma (HCC).
CCAT1 expression levels in 66 pairs of HCC tissues and pair-matched noncancerous hepatic tissues were tested by real-time PCR. The effects of CCAT1 on HCC cells proliferation and migration were assessed using in vitro cell proliferation and migration assays. A computational screen of microRNAs (miRNAs) target sites in CCAT1 was conducted to search for specific miRNAs binding to CCAT1. The specific binding between CCAT1 and miRNAs was confirmed by RNA immunoprecipitation assay combined with luciferase reporter assay.
CCAT1 levels are markedly increased in HCC tissues compared with pair-matched noncancerous hepatic tissues. Up-regulation of CCAT1 is correlated with tumor size, microvascular invasion, AFP and poor prognosis. CCAT1 promotes the proliferation and migration of HCC cells. CCAT1 functions as a molecular sponge for let-7, antagonizes its functions, and leads to the de-repression of its endogenous targets HMGA2 and c-Myc. The effect of CCAT1 on HCC cell proliferation and migration is dependent upon its competitively binding to let-7.
These data suggest that CCAT1 plays a pivotal role in HCC progression via functioning as let-7 sponge, and implicate the potential application of CCAT1 for the prognosis and treatment of HCC.
长链非编码RNA(lncRNAs)已被证实参与癌症生物学过程,且在多种癌症中表达失调。本研究旨在确定长链非编码RNA CCAT1在肝细胞癌(HCC)进展中的表达、作用及功能机制。
采用实时PCR检测66对HCC组织及配对的癌旁肝组织中CCAT1的表达水平。运用体外细胞增殖和迁移实验评估CCAT1对HCC细胞增殖和迁移的影响。对CCAT1中的微小RNA(miRNA)靶位点进行计算机筛选,以寻找与CCAT1特异性结合的miRNA。通过RNA免疫沉淀实验结合荧光素酶报告基因实验确认CCAT1与miRNA之间的特异性结合。
与配对的癌旁肝组织相比,HCC组织中CCAT1水平显著升高。CCAT1的上调与肿瘤大小、微血管侵犯、甲胎蛋白及预后不良相关。CCAT1促进HCC细胞的增殖和迁移。CCAT1作为let-7的分子海绵,拮抗其功能,导致其内源靶标HMGA2和c-Myc去抑制。CCAT1对HCC细胞增殖和迁移的影响取决于其与let-7的竞争性结合。
这些数据表明CCAT1通过作为let-7海绵在HCC进展中起关键作用,并提示CCAT1在HCC预后和治疗中的潜在应用价值。